Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Raw Material Inspection for MDIs

Posted on By

SOP for Raw Material Inspection for MDIs

Raw Material Inspection Procedures for MDIs

1) Purpose

The purpose of this SOP is to establish procedures for the inspection and acceptance of raw materials used in the manufacturing of metered-dose inhalers (MDIs) to ensure quality, safety, and compliance with specifications.

2) Scope

This SOP applies to all personnel involved in the inspection and sampling of raw materials at the MDI production facility, including quality control personnel, procurement officers, and production supervisors.

3) Responsibilities

The responsibilities for this SOP include conducting inspections, sampling raw materials, performing tests as required, and documenting inspection results. Specific roles include:
Quality Control Personnel: Perform inspections and tests according to approved procedures.
Procurement Officers: Ensure raw materials meet specifications before acceptance.
Production Supervisors: Monitor raw material storage and handling to prevent mix-ups or contamination.

See also  SOP for Homogeneity Testing in MDIs

4) Procedure

4.1 Receipt and Sampling
4.1.1 Receive raw materials in designated receiving areas and verify accompanying documentation.
4.1.2 Sample raw materials according to sampling plans or sampling procedures.
4.2 Visual Inspection
4.2.1 Inspect raw materials for visible defects, damage, or discrepancies with accompanying documentation.
4.2.2 Record inspection findings and document any deviations observed.
4.3 Physical and

Chemical Testing
4.3.1 Perform physical tests (e.g., appearance, weight) and chemical tests (e.g., identity, purity) as per specifications.
4.3.2 Use validated test methods and equipment for testing raw materials.
4.4 Acceptance Criteria
4.4.1 Compare test results against established acceptance criteria and specifications.
4.4.2 Determine acceptance or rejection of raw materials based on test results and quality standards.
4.5 Documentation and Release
4.5.1 Document inspection and test results in raw material inspection records or batch records.
4.5.2 Release accepted raw materials for use in production upon completion of inspection and testing.

See also  SOP for Warehouse Management for MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure

6) Documents, if any

Raw material specifications, sampling plans, test methods, inspection records, and release certificates should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for raw material testing and acceptance criteria in pharmaceutical manufacturing.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Tablet Sorting Machine
Next Post: SOP for Documentation in Powders Production

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version